1 terminated, 1 withdrawn. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 1, Withdrawn 1 |
Follow Jimma University: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MMV390048 POC in Patients With P. Vivax and P. Falciparum Malaria MMV390048 - Malaria | Phase 2 | Terminated | Medicines for Malaria Venture | 8 | 2017-10-20 | 2021-12-09 |
| Methylene Blue Against Vivax Malaria in Ethiopia Artemeter-Lumefantrine and MB (combination therapy), Artemeter-Lumefantrine (combination therapy), Artemeter-Lumefantrine and Primaquine (combination therapy) - Vivax Malaria | Phase 2 | Withdrawn | Heidelberg University | 2016-04-01 | 2020-03-25 |
Malaria (1) · Malaria, Vivax (1)
3,7-bis(diethylamino)phenothiazin-5-ium (1) · Combined Modality Therapy (1) · MMV390048 (1) · Primaquine (1)
Ethiopia (1)
Esayas Gudina, MD (1) · Mezgebu Silamsaw, MD (1)